Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression

Ilaria Malanchi, Rosita Accardi, Frank Diehl, Anouk Smet, Elliot Androphy, Jörg Hoheisel, Massimo Tommasino

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

We show that E6 proteins from benign human papillomavirus type 1 (HPV1) and oncogenic HPV16 have the ability to alter the regulation of the G1/S transition of the cell cycle in primary human fibroblasts. Overexpression of both viral proteins induces cellular proliferation, retinoblastoma (pRb) phosphorylation, and accumulation of products of genes that are negatively regulated by pRb, such as p16INK4a, CDC2, E2F-1, and cyclin A. Hyperphosphorylated forms of pRb are present in E6-expressing cells even in the presence of ectopic levels of p16INK4a. The E6 proteins strongly increased the cyclin A/cyclin-dependent kinase 2 (CDK2) activity, which is involved in pRb phosphorylation. In addition, mRNA and protein levels of the CDK2 inhibitor p21WAF1/CIP1 were strongly down-regulated in cells expressing E6 proteins. The down-regulation of the p21WAF1/CIP1 gene appears to be independent of p53 inactivation, since HPV1 E6 and an HPV16 E6 mutant unable to target p53 were fully competent in decreasing p21 WAF1/CIP1 levels. E6 from HPV1 and HPV16 also enabled cells to overcome the G1 arrest imposed by oncogenic ras. Immunofluorescence staining of cells coexpressing ras and E6 from either HPV16 or HPV1 revealed that antiproliferative (p16INK4a) and proliferative (Ki67) markers were coexpressed in the same cells. Together, these data underline a novel activity of E6 that is not mediated by inactivation of p53.

Original languageEnglish (US)
Pages (from-to)13769-13778
Number of pages10
JournalJournal of Virology
Volume78
Issue number24
DOIs
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Retinoblastoma Protein
Human papillomavirus 16
Papillomaviridae
protein phosphorylation
Retinoblastoma
cell cycle
Cell Cycle
Phosphorylation
Cyclin-Dependent Kinase 2
Cyclin A
cyclin-dependent kinase
cyclins
cells
phosphorylation
inactivation
proteins
Proteins
viral proteins
Viral Proteins
fluorescent antibody technique

ASJC Scopus subject areas

  • Immunology

Cite this

Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. / Malanchi, Ilaria; Accardi, Rosita; Diehl, Frank; Smet, Anouk; Androphy, Elliot; Hoheisel, Jörg; Tommasino, Massimo.

In: Journal of Virology, Vol. 78, No. 24, 12.2004, p. 13769-13778.

Research output: Contribution to journalArticle

Malanchi, Ilaria ; Accardi, Rosita ; Diehl, Frank ; Smet, Anouk ; Androphy, Elliot ; Hoheisel, Jörg ; Tommasino, Massimo. / Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. In: Journal of Virology. 2004 ; Vol. 78, No. 24. pp. 13769-13778.
@article{8d1531166db247c18418bb590c64f666,
title = "Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression",
abstract = "We show that E6 proteins from benign human papillomavirus type 1 (HPV1) and oncogenic HPV16 have the ability to alter the regulation of the G1/S transition of the cell cycle in primary human fibroblasts. Overexpression of both viral proteins induces cellular proliferation, retinoblastoma (pRb) phosphorylation, and accumulation of products of genes that are negatively regulated by pRb, such as p16INK4a, CDC2, E2F-1, and cyclin A. Hyperphosphorylated forms of pRb are present in E6-expressing cells even in the presence of ectopic levels of p16INK4a. The E6 proteins strongly increased the cyclin A/cyclin-dependent kinase 2 (CDK2) activity, which is involved in pRb phosphorylation. In addition, mRNA and protein levels of the CDK2 inhibitor p21WAF1/CIP1 were strongly down-regulated in cells expressing E6 proteins. The down-regulation of the p21WAF1/CIP1 gene appears to be independent of p53 inactivation, since HPV1 E6 and an HPV16 E6 mutant unable to target p53 were fully competent in decreasing p21 WAF1/CIP1 levels. E6 from HPV1 and HPV16 also enabled cells to overcome the G1 arrest imposed by oncogenic ras. Immunofluorescence staining of cells coexpressing ras and E6 from either HPV16 or HPV1 revealed that antiproliferative (p16INK4a) and proliferative (Ki67) markers were coexpressed in the same cells. Together, these data underline a novel activity of E6 that is not mediated by inactivation of p53.",
author = "Ilaria Malanchi and Rosita Accardi and Frank Diehl and Anouk Smet and Elliot Androphy and J{\"o}rg Hoheisel and Massimo Tommasino",
year = "2004",
month = "12",
doi = "10.1128/JVI.78.24.13769-13778.2004",
language = "English (US)",
volume = "78",
pages = "13769--13778",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "24",

}

TY - JOUR

T1 - Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression

AU - Malanchi, Ilaria

AU - Accardi, Rosita

AU - Diehl, Frank

AU - Smet, Anouk

AU - Androphy, Elliot

AU - Hoheisel, Jörg

AU - Tommasino, Massimo

PY - 2004/12

Y1 - 2004/12

N2 - We show that E6 proteins from benign human papillomavirus type 1 (HPV1) and oncogenic HPV16 have the ability to alter the regulation of the G1/S transition of the cell cycle in primary human fibroblasts. Overexpression of both viral proteins induces cellular proliferation, retinoblastoma (pRb) phosphorylation, and accumulation of products of genes that are negatively regulated by pRb, such as p16INK4a, CDC2, E2F-1, and cyclin A. Hyperphosphorylated forms of pRb are present in E6-expressing cells even in the presence of ectopic levels of p16INK4a. The E6 proteins strongly increased the cyclin A/cyclin-dependent kinase 2 (CDK2) activity, which is involved in pRb phosphorylation. In addition, mRNA and protein levels of the CDK2 inhibitor p21WAF1/CIP1 were strongly down-regulated in cells expressing E6 proteins. The down-regulation of the p21WAF1/CIP1 gene appears to be independent of p53 inactivation, since HPV1 E6 and an HPV16 E6 mutant unable to target p53 were fully competent in decreasing p21 WAF1/CIP1 levels. E6 from HPV1 and HPV16 also enabled cells to overcome the G1 arrest imposed by oncogenic ras. Immunofluorescence staining of cells coexpressing ras and E6 from either HPV16 or HPV1 revealed that antiproliferative (p16INK4a) and proliferative (Ki67) markers were coexpressed in the same cells. Together, these data underline a novel activity of E6 that is not mediated by inactivation of p53.

AB - We show that E6 proteins from benign human papillomavirus type 1 (HPV1) and oncogenic HPV16 have the ability to alter the regulation of the G1/S transition of the cell cycle in primary human fibroblasts. Overexpression of both viral proteins induces cellular proliferation, retinoblastoma (pRb) phosphorylation, and accumulation of products of genes that are negatively regulated by pRb, such as p16INK4a, CDC2, E2F-1, and cyclin A. Hyperphosphorylated forms of pRb are present in E6-expressing cells even in the presence of ectopic levels of p16INK4a. The E6 proteins strongly increased the cyclin A/cyclin-dependent kinase 2 (CDK2) activity, which is involved in pRb phosphorylation. In addition, mRNA and protein levels of the CDK2 inhibitor p21WAF1/CIP1 were strongly down-regulated in cells expressing E6 proteins. The down-regulation of the p21WAF1/CIP1 gene appears to be independent of p53 inactivation, since HPV1 E6 and an HPV16 E6 mutant unable to target p53 were fully competent in decreasing p21 WAF1/CIP1 levels. E6 from HPV1 and HPV16 also enabled cells to overcome the G1 arrest imposed by oncogenic ras. Immunofluorescence staining of cells coexpressing ras and E6 from either HPV16 or HPV1 revealed that antiproliferative (p16INK4a) and proliferative (Ki67) markers were coexpressed in the same cells. Together, these data underline a novel activity of E6 that is not mediated by inactivation of p53.

UR - http://www.scopus.com/inward/record.url?scp=10044279571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044279571&partnerID=8YFLogxK

U2 - 10.1128/JVI.78.24.13769-13778.2004

DO - 10.1128/JVI.78.24.13769-13778.2004

M3 - Article

VL - 78

SP - 13769

EP - 13778

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 24

ER -